Stockreport

A cancer drugmaker and 2 current and former execs will pay more than $20 million to settle charges of misleading investors about its tumor-shrinking drug (CLVS) [The Business Insider]

Clovis Oncology, Inc.  (CLVS) 
Last clovis oncology, inc. earnings: 2/24 04:05 pm Check Earnings Report
PDF Clovis Oncology and its CEO and former CFO will pay more than $20 million to settle charges with the SEC. According to the SEC, Clovis told investors that its drug, Roci [Read more]